| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 73.29B | 92.75B | 78.55B | 68.99B | 70.42B | 57.27B |
| Gross Profit | 64.55B | 75.57B | 70.32B | 64.33B | 66.56B | 54.03B |
| EBITDA | 19.08B | 26.87B | 22.06B | 20.16B | 19.28B | 16.51B |
| Net Income | 13.52B | 15.41B | 13.15B | 11.26B | 10.87B | 9.00B |
Balance Sheet | ||||||
| Total Assets | 5.47T | 5.65T | 5.47T | 5.40T | 5.33T | 5.49T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 218.96B | 161.49B | 230.92B | 484.39B | 790.92B |
| Total Debt | 76.45B | 105.87B | 76.45B | 70.92B | 133.58B | 415.30B |
| Total Liabilities | 5.20T | 5.37T | 5.21T | 5.13T | 5.07T | 5.24T |
| Stockholders Equity | 275.01B | 280.44B | 267.93B | 274.10B | 252.88B | 250.52B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 36.94B | 19.62B | 2.85B | -227.94B | 110.83B |
| Operating Cash Flow | 0.00 | 37.85B | 20.54B | 4.60B | -225.62B | 124.33B |
| Investing Cash Flow | 0.00 | -118.12B | -158.54B | -219.48B | -77.62B | -70.81B |
| Financing Cash Flow | 0.00 | 136.26B | 68.31B | 117.50B | -3.24B | -2.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥249.46B | 19.78 | ― | 3.00% | 21.20% | 17.32% | |
70 Outperform | ¥1.63T | 14.92 | 7.38% | 2.62% | 22.66% | 28.39% | |
69 Neutral | ¥135.55B | 12.68 | ― | 0.58% | 24.02% | 5.60% | |
68 Neutral | ¥287.36B | 18.41 | ― | 2.13% | 15.39% | 26.92% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | ¥291.76B | 10.78 | ― | 2.55% | 18.30% | 38.04% | |
64 Neutral | ¥335.18B | 5.93 | ― | 1.95% | 17.98% | 32.53% |